US Stock MarketDetailed Quotes

Amylyx Pharmaceuticals (AMLX)

Watchlist
  • 14.590
  • +0.680+4.89%
Close Jun 12 16:00 ET
  • 14.590
  • 0.0000.00%
Post 20:01 ET
1.62BMarket Cap-9.86P/E (TTM)

Amylyx Pharmaceuticals (AMLX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
-77.06%87.37M
-100.61%-665K
-99.59%416K
-101.04%-1.02M
Operating revenue
--0
--0
--0
--0
--0
--0
-79.75%87.37M
-100.53%-665K
-99.63%416K
-100.94%-1.02M
Cost of revenue
0
0
0
0
0
0
389.89%124.63M
0
-84.50%809K
32.94%7.42M
Gross profit
0
0
0
0
0
0
-110.49%-37.26M
-100.67%-665K
-100.40%-393K
-109.11%-8.44M
Operating expense
15.81%43.78M
-29.82%153.29M
-8.46%36.61M
-7.78%36.03M
-4.75%42.86M
-59.94%37.8M
-31.00%218.42M
-58.84%39.99M
-50.40%39.07M
-37.88%44.99M
Selling and administrative expenses
3.09%16.17M
-45.00%62.89M
-9.97%15.39M
-9.29%16.17M
-27.75%15.64M
-72.85%15.68M
-39.30%114.33M
-67.27%17.1M
-63.41%17.83M
-50.11%21.65M
Research and development costs
24.82%27.61M
-13.14%90.4M
-7.33%21.21M
-6.51%19.86M
16.58%27.22M
-39.58%22.12M
-18.80%104.08M
-49.03%22.89M
-29.30%21.24M
-19.62%23.35M
Operating profit
-15.81%-43.78M
40.05%-153.29M
9.96%-36.61M
8.70%-36.03M
19.80%-42.86M
69.05%-37.8M
-758.93%-255.68M
-2,202.07%-40.65M
-310.78%-39.46M
-364.52%-53.44M
Net non-operating interest income expense
15.19%2.57M
-32.64%9.3M
42.06%3.29M
-41.22%1.82M
-51.83%1.96M
-48.43%2.23M
-14.52%13.81M
-47.01%2.32M
-25.87%3.1M
4.68%4.07M
Non-operating interest income
15.19%2.57M
-32.64%9.3M
42.06%3.29M
-41.22%1.82M
-51.83%1.96M
-48.43%2.23M
-14.52%13.81M
-47.01%2.32M
-25.87%3.1M
4.68%4.07M
Other net income (expense)
77.61%-75K
98.84%-700K
130.57%362K
99.50%-180K
97.66%-546K
55.15%-335K
-9,031.52%-60.27M
-8.19%157K
-7,347.54%-36.34M
-28,707.41%-23.33M
Special income (charges)
----
--0
--0
--0
--0
----
---59.05M
--0
---36.2M
---22.85M
-Less:Restructuring and merger&acquisition
----
--0
--0
--0
--0
----
--22.85M
--0
--0
--22.85M
-Less:Other special charges
----
----
----
----
----
----
--36.2M
--0
--36.2M
----
Other non- operating income (expenses)
77.61%-75K
42.34%-700K
130.57%362K
-27.66%-180K
-13.04%-546K
55.15%-335K
-83.94%-1.21M
-8.19%157K
71.11%-141K
-496.30%-483K
Income before tax
-14.97%-41.28M
52.11%-144.69M
13.69%-32.95M
52.70%-34.39M
42.99%-41.44M
69.71%-35.91M
-656.45%-302.14M
-689.58%-38.18M
-424.41%-72.7M
-402.83%-72.7M
Income tax
111.70%46K
107.24%46K
0
0
0
-107.82%-393K
-136.39%-635K
0
0
Net income
-14.97%-41.28M
52.03%-144.74M
12.11%-33M
52.70%-34.39M
42.99%-41.44M
69.77%-35.91M
-712.42%-301.74M
-893.62%-37.55M
-447.98%-72.7M
-429.35%-72.7M
Net income continuous Operations
-14.97%-41.28M
52.03%-144.74M
12.11%-33M
52.70%-34.39M
42.99%-41.44M
69.77%-35.91M
-712.42%-301.74M
-893.62%-37.55M
-447.98%-72.7M
-429.35%-72.7M
Minority interest income
Net income attributable to the parent company
-14.97%-41.28M
52.03%-144.74M
12.11%-33M
52.70%-34.39M
42.99%-41.44M
69.77%-35.91M
-712.42%-301.74M
-893.62%-37.55M
-447.98%-72.7M
-429.35%-72.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.97%-41.28M
52.03%-144.74M
12.11%-33M
52.70%-34.39M
42.99%-41.44M
69.77%-35.91M
-712.42%-301.74M
-893.62%-37.55M
-447.98%-72.7M
-429.35%-72.7M
Basic earnings per share
11.90%-0.37
65.46%-1.53
45.45%-0.3
65.42%-0.37
57.01%-0.46
76.00%-0.42
-706.85%-4.43
-885.71%-0.55
-445.16%-1.07
-424.24%-1.07
Diluted earnings per share
11.90%-0.37
65.46%-1.53
45.45%-0.3
65.42%-0.37
57.01%-0.46
76.00%-0.42
-732.86%-4.43
-885.71%-0.55
-456.67%-1.07
-445.16%-1.07
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 000000-77.06%87.37M-100.61%-665K-99.59%416K-101.04%-1.02M
Operating revenue --0--0--0--0--0--0-79.75%87.37M-100.53%-665K-99.63%416K-100.94%-1.02M
Cost of revenue 000000389.89%124.63M0-84.50%809K32.94%7.42M
Gross profit 000000-110.49%-37.26M-100.67%-665K-100.40%-393K-109.11%-8.44M
Operating expense 15.81%43.78M-29.82%153.29M-8.46%36.61M-7.78%36.03M-4.75%42.86M-59.94%37.8M-31.00%218.42M-58.84%39.99M-50.40%39.07M-37.88%44.99M
Selling and administrative expenses 3.09%16.17M-45.00%62.89M-9.97%15.39M-9.29%16.17M-27.75%15.64M-72.85%15.68M-39.30%114.33M-67.27%17.1M-63.41%17.83M-50.11%21.65M
Research and development costs 24.82%27.61M-13.14%90.4M-7.33%21.21M-6.51%19.86M16.58%27.22M-39.58%22.12M-18.80%104.08M-49.03%22.89M-29.30%21.24M-19.62%23.35M
Operating profit -15.81%-43.78M40.05%-153.29M9.96%-36.61M8.70%-36.03M19.80%-42.86M69.05%-37.8M-758.93%-255.68M-2,202.07%-40.65M-310.78%-39.46M-364.52%-53.44M
Net non-operating interest income expense 15.19%2.57M-32.64%9.3M42.06%3.29M-41.22%1.82M-51.83%1.96M-48.43%2.23M-14.52%13.81M-47.01%2.32M-25.87%3.1M4.68%4.07M
Non-operating interest income 15.19%2.57M-32.64%9.3M42.06%3.29M-41.22%1.82M-51.83%1.96M-48.43%2.23M-14.52%13.81M-47.01%2.32M-25.87%3.1M4.68%4.07M
Other net income (expense) 77.61%-75K98.84%-700K130.57%362K99.50%-180K97.66%-546K55.15%-335K-9,031.52%-60.27M-8.19%157K-7,347.54%-36.34M-28,707.41%-23.33M
Special income (charges) ------0--0--0--0-------59.05M--0---36.2M---22.85M
-Less:Restructuring and merger&acquisition ------0--0--0--0------22.85M--0--0--22.85M
-Less:Other special charges --------------------------36.2M--0--36.2M----
Other non- operating income (expenses) 77.61%-75K42.34%-700K130.57%362K-27.66%-180K-13.04%-546K55.15%-335K-83.94%-1.21M-8.19%157K71.11%-141K-496.30%-483K
Income before tax -14.97%-41.28M52.11%-144.69M13.69%-32.95M52.70%-34.39M42.99%-41.44M69.71%-35.91M-656.45%-302.14M-689.58%-38.18M-424.41%-72.7M-402.83%-72.7M
Income tax 111.70%46K107.24%46K000-107.82%-393K-136.39%-635K00
Net income -14.97%-41.28M52.03%-144.74M12.11%-33M52.70%-34.39M42.99%-41.44M69.77%-35.91M-712.42%-301.74M-893.62%-37.55M-447.98%-72.7M-429.35%-72.7M
Net income continuous Operations -14.97%-41.28M52.03%-144.74M12.11%-33M52.70%-34.39M42.99%-41.44M69.77%-35.91M-712.42%-301.74M-893.62%-37.55M-447.98%-72.7M-429.35%-72.7M
Minority interest income
Net income attributable to the parent company -14.97%-41.28M52.03%-144.74M12.11%-33M52.70%-34.39M42.99%-41.44M69.77%-35.91M-712.42%-301.74M-893.62%-37.55M-447.98%-72.7M-429.35%-72.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.97%-41.28M52.03%-144.74M12.11%-33M52.70%-34.39M42.99%-41.44M69.77%-35.91M-712.42%-301.74M-893.62%-37.55M-447.98%-72.7M-429.35%-72.7M
Basic earnings per share 11.90%-0.3765.46%-1.5345.45%-0.365.42%-0.3757.01%-0.4676.00%-0.42-706.85%-4.43-885.71%-0.55-445.16%-1.07-424.24%-1.07
Diluted earnings per share 11.90%-0.3765.46%-1.5345.45%-0.365.42%-0.3757.01%-0.4676.00%-0.42-732.86%-4.43-885.71%-0.55-456.67%-1.07-445.16%-1.07
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More